Item 2. Properties
ITEM 2. PROPERTIES
We do not own any real property. Our primary operations are conducted at the leased facilities summarized in the below table. We believe our facilities are adequate and suitable for our current needs and that we will be able to obtain new or additional leased space in the future, if necessary.
Location of Property
Lease Expiration Date (1)
Purpose
Square Footage (approximate)
10865 Road to the Cure, San Diego, California
September 30, 2033
Corporate headquarters: manufacturing, laboratory and office space
34,348
10865 Road to the Cure, Room 7, San Diego, California
December 31, 2026
Laboratory space
(vivarium)
234
8840 Wilshire Blvd., 2 nd Floor, Beverly Hills, California
April 22, 2026
Office space
1,627
8700 Beverly Blvd., Davis Building, Los Angeles, California
July 31, 2026
Laboratory, manufacturing and office space
1,892
10835 Road to the Cure, Suite 140, San Diego, California
June 30, 2026
Laboratory and office space
11,173
(1) Certain leases have specific options for potential renewal or extensions.
ITEM 3. LEGAL PROCEEDINGS
For information regarding material legal proceedings, please refer to Note 15 – “Commitments and Contingencies – Legal Contingencies” in our consolidated financial statements included in this Annual Report on Form 10-K.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
75
Table of Contents
PART II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.